glp-1 summit About Based Therapeutics Summit: Emerging Indications Curious about GLP-1 medications for

ROI is One Piece of the Value Puzzle As the healthcare landscape shifts toward greater integration of virtual care solutions, it is increasingly important to articulate the Value on Investment (VOI) of virtual care

High discontinuation rates are a real risk for weight loss GLP-1s , with significant downstream clinical and cost consequences when therapy is stopped

June 2026: 110 GLP-1 vision lawsuits have been coordinated into the NAION multidistrict litigation, based on numbers published by the United States Judicial Panel on Multidistrict Litigation on June 1, 2026

Whether amylin acts to reduce food intake by primarily targeting neuronal and/or non-neuronal cell types in the hindbrain or other brain regions is not completely understood [10]

Taper your GLP-1: One option is to taper your GLP-1s instead of just going cold turkey